Satiety · Complete guide
The Science of Satiety: Hunger, Hormones, and Why You Don't Feel Full
What satiety is, which hormones control it (GLP-1, PYY, CCK, leptin and ghrelin), what we know about food noise, and why fullness sometimes doesn't come, according to the research.
Satiety is the feeling of not being hungry after you eat, and it’s run by a system of signals between your gut and your brain. While you eat, stomach stretch and gut hormones such as CCK, GLP-1 and PYY help you stop. Between meals, ghrelin, made in the stomach, nudges you to eat again. Over the long term, leptin and insulin report on your energy stores. There’s no single “fullness hormone”: it’s a team.
In 30 seconds
- Natural GLP-1 rises within 5 to 15 minutes and returns to baseline in 3 to 4 hours; semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1, with an elimination half-life of about 1 week.
- Ghrelin nearly doubled just before each meal and fell to its lowest point within the following hour.
- After two nights with 4 hours in bed, leptin fell 18%, ghrelin rose 28% and hunger rose 24%.
- On an ultra-processed diet, people ate about 508 more calories a day (NIH trial, 2019).
- Semaglutide: In a phase 1 trial, energy intake during an eat-as-much-as-you-like meal was 35% lower than with placebo after 20 weeks.
When the feeling of fullness doesn’t come, there are explanations with real evidence behind them: eating fast, foods with lots of calories in a small volume, short sleep, stress, and the hormonal changes that follow weight loss. Which foods fill you up most is covered in the most filling foods, according to science; this guide explains the why.
The satiety signals at a glance
| Signal | Where it’s made | What it does | Timing |
|---|---|---|---|
| Stomach stretch | Stretch sensors in the stomach wall, which signal the brain through the vagus nerve | Helps end the meal; on its own, it only stops eating at volumes larger than a normal meal | While the stomach is full |
| CCK (cholecystokinin) | Duodenum and first part of the jejunum (the start of the small intestine) | The best-proven hormonal “stop eating” signal in people: it reduces meal size | Rises within 10 to 15 minutes; after a large meal, peaks around 60 to 90 minutes |
| GLP-1 (glucagon-like peptide-1) | Small intestine, mostly its last section, and large intestine | Contributes to ending the meal and stimulates insulin when blood sugar rises | Rises within 5 to 15 minutes and returns to baseline in 3 to 4 hours; inactivated very quickly in the blood |
| PYY (peptide YY) | End of the small intestine (ileum) and colon | Thought to slow stomach emptying; given by infusion it reduces how much people eat, but its natural role is unclear | Starts rising at 15 to 30 minutes, peaks at 60 to 90, and stays high for several hours |
| Ghrelin | Stomach | The “hunger hormone”: rises before meals and falls when you eat | Bottoms out within an hour of eating and climbs again until the next meal |
| Leptin | Fat tissue | Tells the brain about fat stores | Its background level tracks body fat; it also varies through the day |
| Insulin | Pancreas | Regulates blood sugar and also reports on energy stores | Rises with each meal; its background level reflects the long term |
Timing and roles: reviews by Steinert and colleagues (2017) and Cummings and Overduin (2007); ghrelin, Cummings and colleagues (2001); leptin, Klok and colleagues (2007). The GLP-1 timings are after drinking glucose.
Satiation and satiety: two different processes
In a 2010 review, John Blundell’s group proposes these working definitions:
- Hunger: the conscious sense of urgency to eat. You can feel it in your stomach, your head or your limbs, and when it’s intense it can include weakness, dizziness or an empty feeling in the stomach.
- Satiation: the process that makes you stop eating. It sets the size of the meal.
- Satiety: what, once the meal is over, holds off eating again, lowers hunger and keeps you feeling full. It sets how long it takes for hunger to come back.
The same review is framed around the “satiety cascade”, a model Blundell proposed more than three decades ago. First come sensory and cognitive factors: taste, texture and how filling you expect the food to be. Then come signals from the stomach and gut. Last come the nutrients once they’ve been absorbed.
The review includes two useful data points. In a field study of US soldiers, covering about 5,700 main meals and 8,800 snacks, people finished the whole serving 80% to 90% of the time: the plate has a lot of say. And eating 500 g (about 1.1 lb) of apple takes about 17 minutes, while the same amount as juice goes down in 1.5.
Gut signals: stomach, CCK, GLP-1 and PYY
According to the review by Cummings and Overduin, food produces satiation in two ways: by stretching the stomach and by releasing hormones from cells in the gut. These fast signals reach the brainstem, the part of the brain that connects to the spinal cord, through the vagus nerve or the bloodstream.
Your stomach measures volume, not calories
The stomach has sensors for tension, stretch and volume. It detects how much is in there, not what it is: in experiments that closed off the stomach’s outlet, volume, not nutrients, was what curbed eating. But stretch alone only stops a meal at larger-than-usual amounts. And up to 40% of what you eat moves on to the intestine before you finish, so stomach and gut signals add up from the start.
CCK: the best-proven “stop” signal
The review by Steinert and colleagues considers cholecystokinin the best-established hormonal satiation signal in people. In three studies, infusing CCK at meal-like levels reduced meal size without unpleasant effects. And blocking its receptor did the opposite: more hunger before eating, less fullness and bigger meals. Fat releases the most CCK per calorie; protein somewhat less; carbohydrates the least.
GLP-1: more famous for the drugs than for its natural role
GLP-1 is made in the gut, mostly in its last section. In several studies, infusing it at physiological levels reduced how much normal-weight men ate, though not in all of them. And blocking its receptor didn’t increase meal size in healthy people under five different conditions. Natural GLP-1 contributes, but its weight in everyday satiety is less clear than CCK’s.
On top of that, an enzyme called DPP-4 inactivates it almost as soon as it’s released: in pigs, only 10% to 15% of active GLP-1 reached the general circulation.
PYY: a brake with more questions than answers
PYY is released further down, in the ileum and colon, especially after fatty meals. It takes longer to rise and stays high for several hours. In a 2003 trial with 12 people with obesity and 12 without, a PYY infusion reduced how much they ate at a buffet two hours later: by 30% and 31%, respectively. People with obesity had lower fasting PYY levels.
Steinert and colleagues add a caveat to that finding. The doses that reduced intake raised PYY above what almost any meal produces, except very large ones. In fasting people, that dose caused nausea or marked discomfort in half the participants of two studies. So its role as a natural satiety signal remains unproven.
Leptin, ghrelin and insulin: the hormones of hunger and energy stores
Ghrelin, the “hunger hormone”
In a 2001 study, researchers took 38 blood samples over 24 hours from 10 healthy people eating at fixed times. Ghrelin nearly doubled just before each meal and fell to its lowest point within the following hour. Its curve was the mirror image of insulin’s.
The nickname is a simplification. According to Steinert, the hunger people report tracks the rise and fall of ghrelin well. But an infusion at near-physiological doses, after eating, didn’t change hunger or the next meal; higher doses before eating did increase intake. The Klok review adds a surprising detail: in people with obesity, ghrelin is lower, not higher.
Leptin: the fuel gauge
Leptin is made by fat cells. In a 1996 study with 136 normal-weight people and 139 people with obesity, its level correlated strongly with body fat percentage (r = 0.85). People with obesity had about four times as much.
If leptin curbs appetite, why isn’t having more enough? Because, according to Klok, obesity involves leptin resistance: the brain responds to it less.
Insulin: the other energy-store signal
Insulin regulates blood sugar, but it also informs the brain. Cummings and Overduin describe leptin and insulin as slow-acting “adiposity” hormones. They work like a volume knob: they adjust how much attention the brain pays to the fast gut signals. That way, everyday hunger adapts to your long-term energy balance.
The brain: hypothalamus, reward and “food noise”
Hypothalamus and brainstem
Fast gut signals reach the brainstem, at the nucleus of the solitary tract and the area postrema, according to Cummings and Overduin. Long-term signals such as leptin act mainly on the hypothalamus, a small region at the base of the brain. The Schwartz review in Nature describes circuits of neurons there that stimulate or suppress appetite in response to those hormones.
The reward system
We don’t eat only because we need energy. Lutter and Nestler describe two complementary drives. The homeostatic drive increases the urge to eat when stores run low. The hedonic, or reward, drive can override the first when there’s plenty of energy and increases the desire for highly palatable foods. It helps explain why dessert can sound good even when you’re full.
Food noise
“Food noise” is an informal term, not a diagnosis. According to a 2023 narrative review, it grew out of what patients and clinicians described: on GLP-1 medications, many people said they thought about food far less. The authors propose describing it as heightened or persistent reactivity to food cues, which produces intrusive thoughts and unhealthy eating behaviors.
Research with actual data is recent and scarce:
- A validated questionnaire (2025). The Food Noise Questionnaire defines food noise as persistent, intrusive thoughts about food that disrupt daily life. It has 5 questions and scores from 0 to 20. In 396 adults it proved reliable, but the authors call for more studies on its clinical usefulness. Four of the authors are employees or shareholders of WW International.
- A semaglutide survey (2026). In the INFORM survey, 550 US adults on semaglutide for weight management recalled what their food noise was like before treatment. The median score dropped from 13 to 6. But it relies on memory, has no comparison group, drew on a consumer panel and was commissioned by the manufacturer, Novo Nordisk.
My take: the phenomenon seems real and can now be measured, but I haven’t found published controlled trials that measure it as a primary outcome. The most solid evidence is what the EU prescribing information for Wegovy says about food cravings, which I cite below. Food noise and hunger aren’t the same thing: you can have persistent thoughts about food without physical hunger.
Why you sometimes don’t feel full
You eat fast
A meta-analysis of 22 studies found that eating more slowly is linked to eating less at that meal, although results varied a lot between studies. It didn’t change hunger at the end of the meal or over the next 3.5 hours. One possible explanation, which the meta-analysis doesn’t prove, is that gut signals take minutes to rise and eating fast gives them less time.
A lot of energy in a small volume
Barbara Rolls sums up a line of trials: we tend to eat a fairly constant weight of food. If that weight carries more calories per gram, we eat more calories without feeling any fuller. Food-by-food examples are in the guide to the most filling foods.
Ultra-processed foods
In the 2019 NIH trial, 20 adults living on a research ward ate an ultra-processed diet for two weeks and an unprocessed diet for two weeks, as much as they wanted. On the ultra-processed diet they ate about 508 more calories a day, and ate faster, without rating it as tastier. On the unprocessed diet, PYY went up and ghrelin went down compared with baseline. According to the authors, one contributing factor was that the ultra-processed foods, not counting drinks, had about 85% more calories per gram. It’s a small, short trial.
Short sleep
In a 2004 crossover trial, 12 young men spent two nights with 4 hours in bed and two with 10. After short sleep, leptin fell 18%, ghrelin rose 28% and hunger rose 24%. Appetite went up 23%, and by 33% to 45% for calorie-dense, carbohydrate-rich foods. In a study of 1,024 adults, habitually sleeping 5 hours instead of 8 was associated with 15.5% lower leptin; sleep on the night before the blood test, with 14.9% higher ghrelin. That’s an association, not proof of cause.
Stress
The review by Adam and Epel proposes a model of “reward-based stress eating.” Cortisol and reward circuits would push toward high-calorie foods, and chronic stress would throw off the action of leptin and insulin. The authors themselves caution that in people, these mechanisms are only beginning to be studied.
After weight loss
In a 2011 study, 50 people with overweight or obesity, without diabetes, started a 10-week program on a very low-calorie diet; average loss was 13.5 kg (29.8 lb). A year later, leptin, PYY, CCK and insulin were still lower than at the start. Ghrelin and reported hunger were still higher. That’s physiology, not a lack of willpower. I explain it in the context of the medications in what happens when you stop Ozempic, Wegovy or Zepbound.
What GLP-1 medications do to these signals
GLP-1 medications don’t just add a little more of the natural hormone. According to the US Wegovy label, semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1, with an elimination half-life of about 1 week. It binds tightly to albumin, a blood protein, which the label says results in decreased renal clearance and protection from degradation. The EU prescribing information adds that it is stabilised against degradation by the DPP-4 enzyme. Natural GLP-1 is inactivated very quickly; the drug lasts days.
On appetite, the US label (sections 12.1 and 12.2) says that:
- GLP-1 regulates appetite. GLP-1 is a physiological regulator of appetite and caloric intake, and the GLP-1 receptor is present in several areas of the brain involved in appetite regulation.
- Semaglutide lowers calorie intake. Semaglutide decreases calorie intake, and the effects are likely mediated by affecting appetite.
- Stomach. Semaglutide delays gastric emptying.
The EU prescribing information for Wegovy (section 5.1) goes into more detail than the US label:
- In the brain. In animal studies, it has direct effects on areas of the hypothalamus and brainstem involved in regulating food intake, and may affect the reward system through brain areas including the septum, thalamus and amygdala.
- In clinical studies. It reduces energy intake, increases feelings of satiety, fullness and control of eating, and reduces hunger and the frequency and intensity of cravings. It also reduces the preference for high-fat foods.
- A number. In a phase 1 trial, energy intake during an eat-as-much-as-you-like meal was 35% lower than with placebo after 20 weeks.
- Cravings at two years. In the STEP 5 trial, at week 104, control of cravings and craving for savory food favored semaglutide, with no clear effect on craving for sweet food.
- Stomach emptying. It describes a minor delay in gastric emptying in the early phase after a meal.
Tirzepatide (Zepbound, Mounjaro) acts on the GLP-1 receptor and on the receptor for GIP, another gut hormone. The Zepbound label says that nonclinical studies suggest the addition of GIP may further contribute to the regulation of food intake.
This describes how the drugs work; it isn’t a recommendation. Whether treatment is right for you is a decision for your doctor. The natural hormone and the other drugs in this family are covered in what GLP-1 medications are. If you already take one, the challenge is often making the little you eat cover what you need; I go through it in what to eat on GLP-1 medications.
How to make satiety work for you
None of this is a diet or a plan to eat less. These are ways to use your body’s signals so you reach your next meal without overwhelming hunger.
- Protein at meals. A 2015 review finds a modest effect: more fullness and higher levels of satiety hormones. How much you need depends on your weight and activity; you can estimate it with the protein calculator (in Spanish, in kilograms).
- Volume and fiber. Your stomach measures volume, so foods with lots of water fill you up more per calorie. Fiber helps less than people claim: in a systematic review, only 39% of fiber treatments reduced appetite. You can look for options in our food pages (in Spanish) or with the filling-foods finder (in Spanish).
- Chew and take your time. Whole fruit makes you eat more slowly than juice, and in Robinson’s meta-analysis eating more slowly was linked to eating less at that meal.
- Meal timing. Ghrelin rises before your usual meal times, and sleep shapes its morning level, according to Steinert. That’s a fact about physiology, not a rule: no trial shows that a particular schedule fills you up more.
- Sleep. Two short nights were enough to raise hunger in the Spiegel trial.
If food makes you anxious, if you skip meals to make up for eating, or if hunger frightens you, talk to a health professional.
When hunger is a warning sign
When to call your doctor
Being hungry is normal. But an unexplained, persistent increase in appetite is worth a visit to your doctor. According to MedlinePlus, causes can include anxiety, certain medicines (such as corticosteroids), bulimia, diabetes, Graves disease or hyperthyroidism, low blood sugar (hypoglycemia) and premenstrual syndrome. MedlinePlus also says not to stop taking a medicine without talking to your provider first.
- Possible diabetes. Among the early symptoms of type 2 diabetes, MedlinePlus lists hunger, increased thirst, increased urination, blurred vision, fatigue, and infections that are more frequent or heal slowly. Often there are no symptoms at first.
- Possible eating disorder. According to MedlinePlus, symptoms of binge-eating disorder include eating even when you’re full or not hungry, eating fast during binges, eating until you’re uncomfortably full, eating alone or in secret, and feeling distressed, ashamed or guilty about your eating. Eating disorders are serious mental health conditions, there are treatments that help, and it’s important to reach out.
In any of these cases, talk to your doctor.
Frequently asked questions
What is the fullness hormone?
There isn’t just one. During a meal, CCK, GLP-1 and PYY are at work; over the long term, leptin and insulin. CCK is the best proven in people.
What’s the difference between leptin and ghrelin?
Leptin comes from body fat and reports on long-term stores. Ghrelin comes from the stomach, rises before each meal and falls within the following hour. One works over months; the other, over hours.
Why don’t I feel full even after eating a lot?
The best-supported causes are eating fast, meals with lots of calories in a small volume, ultra-processed foods, short sleep and stress. After weight loss, hormones push toward more hunger: in one study, the change was still there a year later. If excessive hunger is persistent and has no explanation, talk to your doctor.
How long does it take to feel full?
There’s no exact number. CCK rises within 10 to 15 minutes once food reaches the intestine, and GLP-1 within 5 to 15 minutes after drinking glucose. PYY takes 15 to 30 minutes and lasts for hours.
What is food noise?
An informal term for persistent, intrusive thoughts about food. Since 2025 there’s a validated questionnaire to measure it; the data with medications so far come from a retrospective survey.
Can you boost GLP-1 naturally?
Eating releases it, mostly in the last section of the gut, but it’s inactivated very quickly. Semaglutide resists that breakdown and lasts about a week. No food reproduces that. I don’t review or recommend GLP-1 supplements; if you’re considering one, talk to your doctor or pharmacist.
Is being hungrier after losing weight a lack of willpower?
No. In the Sumithran study, a year after weight loss, leptin, PYY and CCK were still lower and ghrelin and hunger still higher. It’s your body’s response; if it’s making daily life hard, talk to a professional.
Sources
- Other sourceBlundell J, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11(3):251-270. doi:10.1111/j.1467-789X.2010.00714.x. Obesity Reviews.
- Other sourceSteinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB. Physiol Rev. 2017;97(1):411-463. doi:10.1152/physrev.00031.2014. Physiological Reviews (American Physiological Society).
- Other sourceCummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117(1):13-23. doi:10.1172/JCI30227. Journal of Clinical Investigation.
- Other sourceCummings DE, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714-1719. doi:10.2337/diabetes.50.8.1714. Diabetes (American Diabetes Association).
- Other sourceKlok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007;8(1):21-34. doi:10.1111/j.1467-789X.2006.00270.x. Obesity Reviews.
- Other sourceConsidine RV, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334(5):292-295. doi:10.1056/NEJM199602013340503. New England Journal of Medicine.
- Clinical trialBatterham RL, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349(10):941-948. doi:10.1056/NEJMoa030204. New England Journal of Medicine.
- Other sourceSchwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661-671. doi:10.1038/35007534. Nature.
- Other sourceLutter M, Nestler EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr. 2009;139(3):629-632. doi:10.3945/jn.108.097618. The Journal of Nutrition.
- Other sourceHayashi D, et al. What Is Food Noise? A Conceptual Model of Food Cue Reactivity. Nutrients. 2023;15(22):4809. doi:10.3390/nu15224809. Nutrients (MDPI).
- Other sourceDiktas HE, et al. Development and validation of the Food Noise Questionnaire. Obesity (Silver Spring). 2025;33(2):289-297. doi:10.1002/oby.24216. Obesity (The Obesity Society).
- Other sourceArnaut T, et al. Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey. Adv Ther. 2026;43(8):3649-3659. doi:10.1007/s12325-026-03636-x. Advances in Therapy (Springer).
- Meta-analysisRobinson E, et al. A systematic review and meta-analysis examining the effect of eating rate on energy intake and hunger. Am J Clin Nutr. 2014;100(1):123-151. doi:10.3945/ajcn.113.081745. American Journal of Clinical Nutrition.
- Other sourceRolls BJ. The relationship between dietary energy density and energy intake. Physiol Behav. 2009;97(5):609-615. doi:10.1016/j.physbeh.2009.03.011. Physiology & Behavior.
- Clinical trialHall KD, et al. Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake. Cell Metab. 2019;30(1):67-77.e3. doi:10.1016/j.cmet.2019.05.008. Cell Metabolism.
- Clinical trialSpiegel K, Tasali E, Penev P, Van Cauter E. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. doi:10.7326/0003-4819-141-11-200412070-00008. Annals of Internal Medicine.
- Other sourceTaheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62. doi:10.1371/journal.pmed.0010062. PLoS Medicine.
- Other sourceAdam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91(4):449-458. doi:10.1016/j.physbeh.2007.04.011. Physiology & Behavior.
- Other sourceSumithran P, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597-1604. doi:10.1056/NEJMoa1105816. New England Journal of Medicine.
- Other sourceLeidy HJ, et al. The role of protein in weight loss and maintenance. Am J Clin Nutr. 2015;101(6):1320S-1329S. doi:10.3945/ajcn.114.084038. American Journal of Clinical Nutrition.
- Other sourceClark MJ, Slavin JL. The effect of fiber on satiety and food intake: a systematic review. J Am Coll Nutr. 2013;32(3):200-211. doi:10.1080/07315724.2013.791194. Journal of the American College of Nutrition.
- Drug labelWegovy (semaglutide) injection and tablets: US Prescribing Information, sections 12.1, 12.2 and 12.3, revised 6/2026. U.S. Food and Drug Administration label, via DailyMed (National Library of Medicine).
- Drug labelZepbound (tirzepatide) injection: US Prescribing Information, sections 12.1 and 12.2, revised 8/2026. U.S. Food and Drug Administration label, via DailyMed (National Library of Medicine).
- Drug labelWegovy (semaglutide): EU Summary of Product Characteristics, sections 5.1 and 5.2 (appetite, food cravings, DPP-4, gastric emptying). European Medicines Agency.
- InstitutionAppetite - increased. MedlinePlus Medical Encyclopedia, US National Library of Medicine (NIH).
- InstitutionType 2 diabetes. MedlinePlus Medical Encyclopedia, US National Library of Medicine (NIH).
- InstitutionEating Disorders. MedlinePlus, US National Library of Medicine (NIH).